Trending Topic

Stastical analysis indication diabetes mellitus .generative ai
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Saptarshi Bhattacharya, Sanjay Kalra, Lakshmi Nagendra

Very few trials in the history of medical science have altered the treatment landscape as profoundly as the UK Prospective Diabetes Study (UKPDS). Even 44 years after its inception, the trial and post-study follow-up findings continue to fascinate and enlighten the medical community. The study was conceived at a time when there was uncertainty about […]

Giulia Brigante, ECE 2023: The challenges of treating patients with hypothryroidism

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 9th 2023

Hypothryroidism is a is a chronic condition in which you have an underactive thyroid where it does not produce enough thyroid hormones. touchENDOCRINOLOGY were delighted to speak with Dr Giulia Brigante (University of Modena and Reggio Emilia, Modena, Italy) about the challenges of treating patients with hypothryroidism.

The abstract ‘RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON LEVOTHYROXINE AND LIOTHYRONINE COMBINATION THERAPY: THE LEVOLIO STUDY‘ was presented at the European Congress of Endocrinology (ECE), 13-16 May 2023.

Questions

  1. What are the challenges of treating patients with hypothryroidism? (0:20)

Disclosures: Giulia Brigante is a consultant for Prolevi Bio.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.

Filmed in coverage of the European Congress of Endocrinology (ECE) Annual Meeting

Click here for more content on thyroid disorders.

Transcript

I’m Giulia Brigante. I’m an endocrinologist. I work as a researcher at the Unit of Endocrinology of the University of Moderna and Reggio Emilia in Italy.

What are the challenges of treating patients with hypothryroidism?

The treatment of hypothyroidism is theoretically quite simple because it is based on the administration of thyroid hormone, thyroxine, which then is activated at the tissue level by deiodinases. But in real life, this mechanism doesn’t seem to be equally efficient in all tissues and in all subjects. Clinical practice and also several studies demonstrated that up to ten, twenty percent of hypothyroid patients treated with this hormone complain of hypothyroidism symptoms despite normal serum TSH levels. We still have to understand which patients should need something more than levothyroxine E alone to recreate a physiological thyroid situation.

Subtitles and transcript are autogenerated.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup